Cortez, Gustavo M.
Monteiro, André
Sourour, Nader
Clarençon, Frédéric
Elhorany, Mahmoud
Grigoryan, Mikayel
Mirza, Soz
Dabus, Guilherme
Linfante, Italo
Aguilar-Salinas, Pedro
Murtaza, Yasmeen
Aghaebrahim, Amin
Sauvageau, Eric
Hanel, Ricardo A. http://orcid.org/0000-0001-7195-5806
Funding for this research was provided by:
Chiesi Foundation (Not applicable)
Article History
Received: 7 September 2020
Accepted: 3 November 2020
First Online: 11 November 2020
Compliance with ethical standards
:
: Dr. Sourour is a consultant for Medtronic, Balt, and Microvention. Dr. Clarençon reports conflict of interest with Medtronic, Guerbet, Balt Extrusion, Penumbra (payment for readings), Codman Neurovascular, and Microvention (core lab). Dr. Dabus is a consultant for Medtronic, Microvention, Cerenovus, and Penumbra. Dr. Linfante is a consultant for Medtronic, Stryker, and Prolong Pharmaceuticals and a stockholder for InNeuroCo and Three Rivers. Dr. Hanel reports conflict of interest with Medtronic, Stryker, Cerenovous, Microvention, Balt, Phenox, MiVI, and Codman and is a stockholder for Neurvana, Elum, Endostream, Three Rivers Medical Inc., Synchron, RisT, Cerebrotech, Deinde, BendIT, and InNeurCo. All the other authors have no disclosure to report.We declare we do not have conflict of interest with the present study.
: Not required.
: This study was approved by each institution local ethics committee. As this was a retrospective analysis, additional written informed consent was waived.